Intensified Methotrexate,Nelarabine & Augmented BFM Ther (AALL0434)

ID Number 80-0066-00055

Principal Investigator(s)
Birte Wistinghausen

Department(s) or Division(s)


The overall goal of this study is to see if we can get rid of the cancer for as long as possible with acceptable side effects of therapy. The purpose of Part I of this study is to collect information on leukemia and the effects of Induction therapy. If patients take part in Part I of this study, they have the option to take part in Part II, which is an experimental option for the next part of their treatment.

Contact Information
Nita Narayan
(212) 241-4142

Recruiting Patients: Yes